Orthofix Medical Inc
NASDAQ:OFIX
Net Margin
Orthofix Medical Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Orthofix Medical Inc
NASDAQ:OFIX
|
627.3m USD |
-16%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
228.5B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
180.6B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
147.4B USD |
11%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
144B USD |
13%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
114B USD |
13%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
65.7B USD |
8%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
56.1B EUR |
9%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
42.4B USD |
77%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
273.8B CNY |
33%
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
36.3B USD |
10%
|
Orthofix Medical Inc
Glance View
Orthofix Medical, Inc. engages in the provision of medical devices. The company is headquartered in Lewisville, Texas and currently employs 1,087 full-time employees. The firm is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The firm has two reporting segments: Global Spine and Global Orthopedics. The Global spine segment provide three product categories such as Bone Growth Therapies, Spinal Implants, and Biologics. Its products also consist of bone growth therapies devices, motion preservation products, spine fixation products, and orthopedics products. The Global Orthopedics offers products and solutions that allow physicians to treat a variety of orthopedic conditions in adults and children unrelated to the spine. The company distribute its products globally to hospitals and health providers.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Orthofix Medical Inc's most recent financial statements, the company has Net Margin of -15.8%.
You don't have any saved screeners yet